The menopause is an event which almost every woman will experience during the later period of their life. Some may embrace this new transition with limited symptoms, whilst others can have serious, sometimes detrimental side effects. These include vaginal dryness/dyspareunia, sleep difficulties, adverse mood changes, cognitive complaints and hot flushes.1
Last year, a new drug Veoza (also called fezolinetant) was approved for use in the UK, and it was officially rolled at last month. The medicine will initially be available prescription-only or privately, according to the manufacturer Astellas.2 The new drug is expected to transform the lives of thousands of women in the UK who are not able to use hormone replacement therapy (HRT).
In a survey of 698 women, 79% experienced hot flushes during the menopause.3 With the menopause and its symptoms becoming more widely spoken about, it raises the question as to how this new drug…
